CL-332-877

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameCL-332-877

Drug Alias NameCL-332,877CL-332877CL-332-877

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of Action +[1] N/A

TargetsAngiotensin II Receptor Type 1

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHypertension

ATC CodeN/A